Literature DB >> 29523670

Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.

William J Gradishar, Benjamin O Anderson, Ron Balassanian, Sarah L Blair, Harold J Burstein, Amy Cyr, Anthony D Elias, William B Farrar, Andres Forero, Sharon H Giordano, Matthew P Goetz, Lori J Goldstein, Steven J Isakoff, Janice Lyons, P Kelly Marcom, Ingrid A Mayer, Beryl McCormick, Meena S Moran, Ruth M O'Regan, Sameer A Patel, Lori J Pierce, Elizabeth C Reed, Kilian E Salerno, Lee S Schwartzberg, Amy Sitapati, Karen Lisa Smith, Mary Lou Smith, Hatem Soliman, George Somlo, Melinda L Telli, John H Ward, Rashmi Kumar, Dorothy A Shead.   

Abstract

Ductal carcinoma in situ (DCIS) of the breast represents a heterogeneous group of neoplastic lesions in the breast ducts. The goal for management of DCIS is to prevent the development of invasive breast cancer. This manuscript focuses on the NCCN Guidelines Panel recommendations for the workup, primary treatment, risk reduction strategies, and surveillance specific to DCIS.
Copyright © 2018 by the National Comprehensive Cancer Network.

Entities:  

Mesh:

Year:  2018        PMID: 29523670     DOI: 10.6004/jnccn.2018.0012

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  111 in total

Review 1.  The breast surgeons' approach to mastectomy and prepectoral breast reconstruction.

Authors:  Toni Storm-Dickerson; Noemi M Sigalove
Journal:  Gland Surg       Date:  2019-02

2.  Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study.

Authors:  Emmanuel S Antonarakis; Josep M Piulats; Marine Gross-Goupil; Jeffrey Goh; Kristiina Ojamaa; Christopher J Hoimes; Ulka Vaishampayan; Ranaan Berger; Ahmet Sezer; Tuomo Alanko; Ronald de Wit; Chunde Li; Aurelius Omlin; Giuseppe Procopio; Satoshi Fukasawa; Ken-Ichi Tabata; Se Hoon Park; Susan Feyerabend; Charles G Drake; Haiyan Wu; Ping Qiu; Jeri Kim; Christian Poehlein; Johann Sebastian de Bono
Journal:  J Clin Oncol       Date:  2019-11-27       Impact factor: 44.544

3.  Radiation Therapy After Breast-Conserving Surgery in Women 70 Years of Age and Older: How Wisely Do We Choose?

Authors:  Stephanie Downs-Canner; Emily C Zabor; Tyler Wind; Armend Cobovic; Beryl McCormick; Monica Morrow; Alexandra Heerdt
Journal:  Ann Surg Oncol       Date:  2019-02-08       Impact factor: 5.344

4.  Consolidation of Cancer Registry and Administrative Claims Data on Cancer Diagnosis and Treatment in the US Military Health System.

Authors:  Yvonne L Eaglehouse; Amie B Park; Matthew W Georg; Derek W Brown; Jie Lin; Stephanie Shao; Julie A Bytnar; Craig D Shriver; Kangmin Zhu
Journal:  JCO Clin Cancer Inform       Date:  2020-10

5.  Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer.

Authors:  Kirsten A Nyrop; Allison M Deal; Shlomit S Shachar; Ethan Basch; Bryce B Reeve; Seul Ki Choi; Jordan T Lee; William A Wood; Carey K Anders; Lisa A Carey; Elizabeth C Dees; Trevor A Jolly; Katherine E Reeder-Hayes; Gretchen G Kimmick; Meghan S Karuturi; Raquel E Reinbolt; JoEllen C Speca; Hyman B Muss
Journal:  Oncologist       Date:  2018-12-14

Review 6. 

Authors:  Anna N Wilkinson; Catherine E Boutet
Journal:  Can Fam Physician       Date:  2020-05       Impact factor: 3.275

7.  Multidisciplinary Management of Breast Cancer With Extensive Regional Nodal Involvement.

Authors:  Benjamin D Smith; Matthew P Goetz; Judy C Boughey
Journal:  J Clin Oncol       Date:  2020-05-22       Impact factor: 44.544

Review 8.  De-Escalation of Locoregional Therapy in Low-Risk Disease for DCIS and Early-Stage Invasive Cancer.

Authors:  E Shelley Hwang; Lawrence Solin
Journal:  J Clin Oncol       Date:  2020-05-22       Impact factor: 44.544

9.  Feasibility of lung cancer RNA acquisition from a single transbronchial or transthoracic needle pass (FASTT trial).

Authors:  Travis Dotson; Christina Bellinger; Jing Su; Kris Hansen; Graham E Parks; James O Cappellari; Lou Craddock; Hollins Clark; Clifford Howard; W Jeffrey Petty; Bharat Prakash; Kounosuke Watabe; Michael Chan; Jonathan Hovda; Lance D Miller; Jimmy Ruiz
Journal:  Lung Cancer       Date:  2018-11-20       Impact factor: 5.705

10.  HER2 assessment by bright-field dual in situ hybridization in cell blocks of recurrent and metastatic breast carcinoma.

Authors:  Marcia Edelweiss; Ana Paula Martins Sebastiao; Handy Oen; Mihaela Kracun; Rene Serrette; Dara S Ross
Journal:  Cancer Cytopathol       Date:  2019-09-22       Impact factor: 5.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.